Conference Proceedings

View Meeting Video

Friday, January 23, 2026  |  7:00 am - 4:00 pm
In-person 
Hilton Philadelphia City Avenue, 4200 City Avenue, Philadelphia, PA, 19132

AGENDA

7:00 am

Check-in, Breakfast, and Visit Exhibits

8:00 am

Welcome and Introductions

Edward A. Stadtmauer, MD  |  Activity Director

Robert H. Vonderheide, MD, DPhil  |  Director, Abramson Cancer Center

SESSION I: NEW THERAPIES AND CURRENT PATIENT MANAGEMENT OF LYMPHOMAS

MODERATOR: Sunita D. Nasta, MD, FACP  

8:15 am

Sequencing New Therapies in Follicular Lymphoma

8:30 am

Advances in CLL/SLL

8:45 am

Updates in Management of Hodgkin Lymphoma

Jakub Svoboda, MD  |  Activity Co-Director

9:00 am

Therapeutic Advances in T-Cell Lymphomas

9:15 am

Novel Approaches to Managing Large B-Cell Lymphomas

9:30 am

Evolving Treatment Strategies in Mantle Cell Lymphoma

10:15 am

Break and Visit Exhibits

SESSION II: UPDATE IN BLOOD, MARROW TRANSPLANTATION AND CELLULAR THERAPY

MODERATOR: Nasheed M. Hossain, MD  |  Activity Co-Director

10:45 am

Equal Access to Transplant: Mismatched Donors for Blood Cancers

11:00 am

Emerging Novel Approaches to Allogeneic HCT

11:15 am

MODERATORS: Nasheed M. Hossain, MD  |  Activity Co-Director

PANEL:

Nicholas K. Brown, PhD, F(ACHI)  | Pathology and Laboratory Medicine
Michael LaRiviere, MD  |  Radiation Oncology
Shannon R. McCurdy, MD
Pashna N. Munshi, MD
Linda M. Perry, MS, PA-C  

11:45 am

Lunch Break and Visit Exhibits

SESSION III: UPDATE ON PATIENT CARE TREATMENT STRATEGIES IN LEUKEMIA

Moderator: Keith W. Pratz, MD  |  Activity Co-Director

  12:45 pm

Emerging Treatment Options for AML

1:00 pm

MDS Bone Marrow Failure Syndromes

1:15 pm

Update in Myeloproliferative Neoplasms

1:30 pm

Next Generation of Cellular Therapies

1:45 pm

Panel Discussion

2:15 pm

Break and Visit Exhibits

SESSION IV: CONTROVERSIES AND UPDATE FOR PATIENT CARE IN MULTIPLE MYELOMA

Moderator: Edward A. Stadtmauer, MD  |  Activity Director

2:35 pm

Smoldering Myeloma and Amyloidosis

2:50 pm

Initial Therapy for Multiple Myeloma Including Transplant

3:05 pm

Role of Immunotherapy for Myeloma

Edward A. Stadtmauer, MD  |  Activity Director 

3:20 pm

Investigational Therapies for Relapsed Myeloma

3:35 pm

Panel Discussion

MODERATOR: Edward A. Stadtmauer, MD  |  Activity Director

PANEL:
Shivani Kapur, MD  
Michael LaRiviere, MD  |  Radiation Oncology
Oxana Megherea, PharmD  |  Oncology Pharmacy
Leah R. Power, MSN, CRNP  
Dan T. Vogl, MD, MSCE  
Adam Waxman, MD, MS  

4:00 pm

Adjourn